Paxillin anticorps (pSer273)
Aperçu rapide pour Paxillin anticorps (pSer273) (ABIN7468712)
Antigène
Voir toutes Paxillin (PXN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pSer273
-
Réactivité croisée
- Humain, Souris
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Carrier-protein conjugated synthetic peptide surrounding phospho Ser273 of human Paxillin. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: A431 (100 nM Calyculin A treatment for 30 min) , C8D30 , NIH-3T3 Validation: Orthogonal
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.04 mg/mL
-
Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Paxillin (PXN)
-
Autre désignation
- paxillin
-
Sujet
- Paxillin
-
Poids moléculaire
- 65 kDa
-
ID gène
- 5829
-
UniProt
- P49023
-
Pathways
- Signalisation MAPK, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Antigène
-